European Journal of Inflammation

请查看我们的作者身份政策，其中包括关于作者身份标准、谁应担任通讯作者等信息。请注意，不应将AI聊天机器人（例如ChatGPT）列为作者。更多信息请参阅关于使用ChatGPT和生成式AI工具的政策。 模型中文摘要

Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

期刊致力于促进研究的开放性、透明度和可重复性，并制定了以下研究数据共享政策。在符合适当的伦理和法律考虑的前提下，鼓励作者：在相关的公共数据存储库中共享您的研究数据；包含链接到您数据的可用性声明。如果无法共享您的数据，请使用该声明确认无法共享的原因。在您的研究中引用这些数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

European Journal of Inflammation is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid…

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题。请阅读Sage关于抄袭的完整政策以及我们可能采取的行动。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

期刊将考虑已在预印本服务器上发布的手稿投稿。请在提交手稿时在指定字段中输入预印本DOI。我们建议您在提交时告知期刊编辑部您已发布的预印本。请注意，在手稿同行评审期间，您不应在预印本服务器上发布手稿的更新版本。了解更多关于我们的预印本政策。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

期刊遵循ICMJE的要求，即临床试验作为考虑发表的条件，必须在首次参与者入组时或之前在WHO批准的公共试验注册中心注册。试验注册中心名称和URL以及注册号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.